Detalhe da pesquisa
1.
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.
Ann Oncol
; 35(4): 364-380, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244928
2.
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Ann Oncol
; 33(8): 769-785, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605746
3.
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
Ann Oncol
; 31(12): 1606-1622, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004253
4.
A decade of clinical development of PARP inhibitors in perspective.
Ann Oncol
; 30(9): 1437-1447, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218365
5.
Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785].
Ann Oncol
; 34(3): 326, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529568
6.
Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress.
Br J Cancer
; 108(4): 983-92, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23361057
7.
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.
Br J Cancer
; 103(8): 1192-200, 2010 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20877358
8.
Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.
Oncogene
; 39(24): 4780, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427987
9.
The genomic profile of HER2-amplified breast cancers: the influence of ER status.
J Pathol
; 216(4): 399-407, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18810758
10.
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer.
Ann Oncol
; 24(5): 1416-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23524863
11.
Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse.
Diabetes
; 50(11): 2633-7, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11679445
12.
Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene.
Diabetes
; 46(4): 695-700, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9075813
13.
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes.
Genetics
; 158(1): 357-67, 2001 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11333244
14.
Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing.
Clin Oncol (R Coll Radiol)
; 32(2): 69-74, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679912
15.
Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers.
Oncogene
; 33(8): 966-76, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23474757
16.
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.
Oncogene
; 33(5): 619-31, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334330
17.
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer.
Oncogene
; 32(47): 5377-87, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934192
18.
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
Oncogene
; 30(41): 4243-60, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552290
19.
RNA interference screening demystified.
J Clin Pathol
; 62(3): 195-200, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19126568
20.
Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer.
Oncogene
; 28(11): 1465-70, 2009 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19182824